It looks like freckles; Red petechiae on her legs, from her knees and down/Red spots became bumpy; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (Red petechiae on her legs, from her knees and down/Red spots became bumpy) and EPHELIDES (It looks like freckles) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003M21A, 032F21A, 011M20A and 029L20A) for COVID-19 vaccination.     Patient was not allergic to medications, food and other products. Patient not had COVID positive test or diagnosis. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Patient had not experienced a similar event in the past.  Concomitant products included APIXABAN (ELIQUIS), PAROXETINE, MEMANTINE, VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID], BIMATOPROST (LUMIGAN) and DORZOLAMIDE for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PETECHIAE (Red petechiae on her legs, from her knees and down/Red spots became bumpy). On 04-May-2022, the patient experienced EPHELIDES (It looks like freckles). At the time of the report, PETECHIAE (Red petechiae on her legs, from her knees and down/Red spots became bumpy) and EPHELIDES (It looks like freckles) was resolving.            There were no symptoms after 1st booster shot. One day after 2nd booster shot, patient experienced red petechiae on her legs, from her knees and down, and one week later red spots became bumpy; it seemed to be resolving, currently it was like freckles.  Patient visited her doctor, but no treatment was given.  Company Comment: This is a Spontaneous case concerning a 94-year-old female patient with no medical history reported but concomitant use of Apixaban, who experienced the non-serious unexpected of Petechiae which occurred on the day after the fourth dose of mRNA-1273. It was reported that there were no symptoms after 1st booster shot. One day after 2nd booster shot, patient experienced red petechiae on her legs, from her knees and down, and one week later red spots became bumpy; it seemed to be resolving, currently it was like freckles. Concomitant anticoagulant therapy with Apixaban could remain as a contributory factor for the event. The patient didn't receive treatment. The benefit-risk relationship of COVID-19 Vaccine Moderna (mRNA-1273) is not affected by this report.   This case was linked to MOD-2022-558945, MOD-2022-559004 (Patient Link). Sender's Comments: This is a Spontaneous case concerning a 94-year-old female patient with no medical history reported but concomitant use of Apixaban, who experienced the non-serious unexpected AESI of Petechiae which occurred on the day after the fourth dose of mRNA-1273. It was reported that there were no symptoms after 1st booster shot. One day after 2nd booster shot, patient experienced red petechiae on her legs, from her knees and down, and one week later red spots became bumpy; it seemed to be resolving, currently it was like freckles. Concomitant anticoagulant therapy with Apixaban could remain as a contributory factor for the event. The patient didn't receive treatment. The benefit-risk relationship of COVID-19 Vaccine Moderna (mRNA-1273) is not affected by this report.